EMO CORP financials
A multi-period view of the public annual-account figures reported for EMO CORP, with comparable measures and links to available source documents.
Company overviewRegistry number
0861630511
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 29, 2026
Financial evidence
Latest movements for EMO CORP
2025 versus 2024
- Operating line
- €30,747
- EBITDA
- €27,952
- Total assets
- €188,565
- Equity
- -€29,296
-41.2%
-44.1%
-9.6%
-181%
EBITDA margin +90.9% · Equity ratio -15.5%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €30,747 | €27,952 | €188,565 | -€29,296 | - |
| 202431 Dec 2024 | €52,328 | €49,975 | €208,587 | -€10,425 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.